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genes for bone microarchitecture
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Abstract
Background: The microstructure of trabecular bone is a composite trait governed by a complex interaction of
multiple genetic determinants. Identifying these genetic factors should significantly improve our ability to predict of
osteoporosis and its associated risks. Genetic mapping using collaborative cross mice (CC), a genetically diverse
recombinant inbred mouse reference panel, offers a powerful tool to identify causal loci at a resolution under one
mega base-pairs, with a relatively small cohort size.
Here, we utilized 31 CC lines (160 mice of both sexes in total) to perform genome-wide haplotype mapping across
77,808 single-nucleotide polymorphisms (SNPs). Haplotype scans were refined by imputation with the catalogue of
sequence variation segregating in the CC to suggest potential candidate genes. Trabecular traits were obtained
following microtomographic analysis, performed on 10-μm resolution scans of the femoral distal metaphysis. We
measured the trabecular bone volume fraction (BV/TV), number (Tb.N), thickness (Tb.Th), and connectivity density
(Conn.D).
Results: Heritability of these traits ranged from 0.6 to 0.7. In addition there was a significant (P < 0.01) sex effect in
all traits except Tb.Th. Our haplotype scans yielded six quantitative trait loci (QTL) at 1 % false discovery rate; BV/TV
and Tb.Th produced two proximal loci each, on chromosome 2 and 7, respectively, and Tb.N and Conn.D yielded
one locus on chromosomes 8 and 14, respectively. We identified candidate genes with previously-reported functions in
bone biology, and implicated unexpected genes whose function in bone biology has yet to be assigned. Based on the
literature, among the genes that ranked particularly high in our analyses (P < 10-6) and which have a validated causal
role in skeletal biology, are Avp, Oxt, B2m (associated with BV/TV), Cnot7 (with Tb.N), Pcsk6, Rgma (with Tb.Th), Rb1, and
Cpb2 (with Conn.D). Other candidate genes strongly suggested by our analyses are Sgcz, Fgf20 (associated with Tb.N),
and Chd2 (with Tb.Th).
Conclusion: We have demonstrated for the first time genome-wide significant association between several genetic
loci and trabecular microstructural parameters for genes with previously reported experimental observations, as well as
proposing a role for new candidate genes with no previously characterized skeletal function.
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Background
Osteoporosis is the most common bone disease, affect-
ing nearly half the US population over the age of
50 years, and is expected to cost over $25.3 billion by
2025 [1] per-annum. Worldwide, the incidence of bone
fractures is expected to increase by 2.7-fold by 2050, due
to population aging [2]. Importantly, women have a 1.5-
fold higher risk of bone fracture than men throughout
their lives as well as a 1.3-fold higher risk of hip or ver-
tebral fracture than their risk of breast cancer [3–5]. A
number of studies have shown that peak bone mass is
tightly affected by host genetic determinants, and low
bone mass significantly increases the risk of osteopor-
osis, especially in the elderly [6]. Risk of fracture is de-
termined largely by the combination of bone structural
parameters associated with bone strength. Most of these
parameters, e.g. trabecular bone density, achieve peak
values at skeletal maturity and subsequently decrease
due to aging and menopause [6]. Microstructural fea-
tures of trabecular bones, as those of cortical bones and
indeed of most phenotypes, are known to be complex
rather than Mendelian traits, determined by the cumula-
tive effects and interactions of numerous genetic loci
and environmental factors [7, 8].
Individuals with the same bone mineral density (BMD)
measured by two dimensional dual energy x-ray absorp-
tiometry (DXA) scans have different risks for fracture,
suggesting that factors other than density, such as
microstructural architecture, are important determinants
of skeletal strength [9]. Recently, a number of genome-
wide association studies (GWAS), including a meta-
analysis, described >50 loci associated with bone mineral
density (BMD) in humans [10–15]. However, many can-
didate genes, such as vasopressin (Avp), oxytocin (Oxt),
and β-2-microglobulin (B2m) were not confirmed by
GWAS, despite their proven role in bone metabolism
[12, 13, 15–18]. Failure to significantly associate these
genes to bone density in GWAS suggests that there may
be other bone phenotypes not yet studied [17], or that
genetic variation segregating in the populations tested does
not influence the expression of these genes appreciably.
Importantly, almost all previous GWAS have used
areal bone mineral density (aBMD) as the sole parameter
for the bone phenotype. Clinically, areal and volumetric
BMD (aBMD and vBMD) do not accurately predict risk
fracture, suggesting that site-specific changes at the micro-
structural level are important determinants of bone
strength. BMD as measured by DXA is a two dimensional
projection that cannot determine or account for bone size,
individual bone compartment shape (trabecular vs cortical),
or the underlying microstructure. Notably, fracture risk and
bone strength are tightly associated with changes in the
bone microstructure, but are not always detected by DXA
and peripheral computed tomography (pQCT) [19]. There
is growing evidence that cortical and trabecular bone have
distinct genetic influences and should be analyzed separ-
ately [15, 16]. Indeed, a recent GWAS in collaborative cross
(CC) mice, based on DXA measurements, failed to reveal
any heritability of BMD [20], whereas our preliminary ana-
lyses in the same mouse panel (some of these data are
as yet unpublished, others are reported herein) show
highly significant heritability levels in most of the
microstructural parameters measured by micro-
computed tomography (μCT).
The CC is a panel of recombinant inbred lines of mice
descended from eight genetically divergent strains [21],
designed for high resolution analysis of complex traits,
with particular emphasis on traits relevant to human
health [22, 23]. In this study we used 31 CC lines which
at the time of the experiment were over 90 % homozy-
gous. GWAS in mice traditionally use rodent inbred line
crosses with poor mapping resolution of 20 to 40 Mb
[24], thus proposing hundreds of genes as potential can-
didates. To narrow the widths of QTLs, combined cross-
analysis and block haplotyping techniques have been
proposed [24, 25]. Mapping resolution in the CC is typ-
ically of the order of 1–2 Mb, due to the increased ex-
tent of observable recombination in the population and
the use of haplotype-based tests of association [18, 22–25].
Genetic variation segregating in the CC is much greater
(over 30 million SNPs, due to the inclusion of three wild-
derived strains) than in a traditional intercross between
standard laboratory strains (about 4 million SNPs) [7]. In
addition to the narrower QTLs typically generated using
the CC panels, this allows the identification of a greater
number of contributing genetic variants as compared to
panels based on classical strains only. Moreover, by using
the extensive catalogues of variation in the founders (see
Keane et al., 2011 [7]) it is possible to impute the variants
into each CC lines and test for association [26]. By merging
the CC founders according to the strain distribution pat-
tern (SDP) of their alleles at potential quantitative trait nu-
cleotides (QTN) within a given QTL (obtained by the
initial haplotype-based mapping) [26, 27], one can refine
the initial haplotype mapping and identify candidate genes.
Here, we aimed to identify new genetic determinants
of bone microarchitecture and metabolism associated
with bone strength in CC mice. In contrast to working
with human populations in which the environment is
uncontrolled and individuals are genetically distinct, in
the CC we could collect phenotypes in a controlled en-
vironment and from multiple individuals with the same
genetic background. We measured microarchitectural
trabecular bone traits, including trabecular bone volume
fraction (BV/TV), trabecular bone number (Tb.N), tra-
becular bone thickness (Tb.Th), and trabecular bone
connectivity (Conn.D) in the distal femoral metaphysis.
Our results provide the first genome-wide confirmation
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of the involvement of several genetic factors in trabecu-
lar bone development as well as suggest new candidate
genes with undocumented roles in bone metabolism.
Results
Trabecular traits vary across the CC population
In each CC animal we analyzed the trabecular bone
compartment of the distal femoral metaphysis and
measured trabecular bone volume fraction (BV/TV;
range = 2.38 – 29.2 %), trabecular number (Tb.N;
range = 0.63 – 5.64 mm-1), trabecular thickness (Tb.Th;
range = 35.95 – 60.0 μm), and trabecular connectivity
(Conn.D; range = 14.0 – 205.09 mm-3). Heritability
(H2) for all traits was greater than 0.6, i.e., genetic
differences between the lines explained most of the
phenotypic variation (Table 1). There was a high pheno-
typic heterogeneity between lines for all traits except for
Tb.Th. While phenotypic heterogeneity was observed in
both males and females, female variability among the lines
was greater (Additional file 1: Figure S1).
Figure 1 shows the phenotypic distribution across
lines, sorted in descending order by their mean. Lines
are color-coded according to Duncan’s least significance
range (LSR). This partitioned the lines to at least three
groups of lines in which each group significantly differs
from the others (P < 0.001). Additional file 2: Table S1
lists the means of the lines for each trait. To emphasize
the phenotype variations across the lines, we identified
the two lines with extreme values for BV/TV, Tb.N, and
Conn.D (Figs. 1 and 2). Interestingly, in all traits except
Tb.Th, IL-1513 was at the upper-most extreme and IL-
2126 and IL-2391 (and in BV/TV also IL-557) were at
the lower-most extreme (Figs. 1 and 2).
Our analyses showed that all phenotypes were approxi-
mately normally distributed and positively correlated with
one another (Additional file 2: Table S2). Pearson’s correl-
ation coefficient (r) ranged between 0.93 for BV/TV vs.
Tb.N, and 0.29 for BV/TV vs. Tb.Th. However, despite
these overall high phenotypic correlations, some lines
were discordant between the bone traits. For example, IL-
670 had high trabecular Conn.D (88.82 mm-3) but average
Tb.N and BV/TV (2.42 mm-1 and 8.8 %), and low Tb.Th
(45.73 μm). IL-557 was in the lower range for BV/TV,
Tb.N and Conn.D (5.3 %, 1.42 mm-1 and 47.86 mm-3) but
was average for Tb.Th (47.43 μm).
Because body weight is often correlated with bone
density [28, 29], we assessed the effect of weight on our
examined traits. Irrespective of sex effects, our data indi-
cate that body weight did not affect any of the analyzed
bone parameters in this animal sample (Pearson’s r ≤
0.11). In contrast, sex had a significant impact on BV/
TV, Tb.N, and Conn.D (P < 0.001), but not on Tb.Th
(Table 1, Fig. 3). Notably, males always averaged higher
for the three traits where we observed a sex effect (Fig. 3
and Additional file 1: Figure S1). Although age was in
the limited range of 10–13 weeks, we did observe a sig-
nificant age effect for BV/TV (P < 0.001, Table 1).
Mapping the albino trait supports a modest number of
CC lines
As a positive control, we performed a QTL mapping for
albinism using the same mice from 31 CC lines in which
we measured the bone traits, and in an additional 7 lines
in which no skeletal analysis was performed (38 lines in
all). Using the same methodology, we were able to map
albinism to its known locus on chromosome 7 [30]. This
confirms that the identities of the phenotyped lines
matched their expected genotypes and provides valid-
ation for using a small number of CC lines for QTL
mapping (Additional file 3: Figure S2).
Haplotype association mapping reveals six QTLs
After adjusting for sex and age and taking the mean for
each line, we performed a haplotype association analysis
(Fig. 4). Using the full database for each trait, we ob-
tained haplotype mappings which were correlated in a
manner that echoed the phenotype correlation; this
practice has limitations in that it can mask important
loci. In other words, the complex nature of the trabecu-
lar traits is prone to loss of information owing to pre-
sumed complementary genetic factors that govern each
trait. This phenomenon dilutes the sample and adds
noise which accumulates false negatives. QTL masking
can also be due to genetic drift occurring in inbred
population of high generation [31, 32]. To overcome this
hindrance we sampled subsets from our cohort and
unlocked otherwise confounded loci (this was achieved
with a minimum of 28 lines); here, therefore, each trait
is founded on the set that maximizes its loci mapping’s
peaks. For BV/TV and Tb.Th, we found two proximal
QTLs for each on chromosome 2 and 7, respectively.
Tb.N and Conn.D yielded one QTL on chromosome 8
and another on chromosome 14, respectively. The two
QTLs for BV/TV, the QTL for Tb.N, the two QTLs for
Tb.Th, and the QTL for Conn.D, are hereafter referred
as trabecular-related loci (Trl) 1 to 6, respectively.
Table 1 Heritability, sex, and age effects for trabecular traits
Trait H2 logP Sex effect Sex logP Age effect Age logP
BV/TV 0.63 15.00 0.65 2.30 0.57 3.80
Tb.N 0.71 15.00 0.72 5.00 - -
Tb.Th 0.56 11.00 0.56 0.04 0.01 15.00
Conn.D 0.67 15.00 0.70 8.58 - -
The Heritability (H2), sex, and age effects and their respective significance
(given as logP = -log10(P value)). Note that except for BV/TV, age effect is negligible,
although the statistic is high for Tb.Th; this is due to the low variability of the age
when compared to the high variability of Tb.Th. When values for both age effect
and its respective P-value are absent both were low
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All QTLs are above the genome-wide 99th percentile
threshold; they were obtained empirically by 200 permu-
tation simulations, with an experiment-wide false discov-
ery rate (FDR) under 1 % for each scan. As shown in
Table 2 and Additional file 4: Figure S3, the respective
widths of the 50 % confidence intervals (CIs) for Trl1 to
6 were 0.2, 0.3, 3.27, 0.2, 0.13, and 9.94 Mb. We also cal-
culated 50 % CIs according to Li’s method (Table 2,
[33]). The CIs obtained by our simulations were
comparable to those calculated after Li, albeit the latter
were usually slightly wider.
We then estimated the regional heritability (H2r) ex-
plained by each QTL and found the combined values
were approximately equal to the genome-wide H2. For
the 6 defined Trl, the H2r range fell between 0.60 and
0.86 (Table 2).
Subsequently, we assessed the haplotype contribution
of the founder strains to each QTL (Fig. 5); Trl1, Trl2,
Fig. 1 Mean trabecular values obtained from 31 CC lines. From top-left, counter-clockwise: trabecular bone volume fraction (BV/TV; %), trabecular
number (Tb.N; mm-1), thickness (Tb.Th; mm), and connectivity density (Conn.D; mm-3). Lines were grouped according to Duncan’s LSR; each color-coded
group is statistically different from all the other groups (P< 0.001; Tukey’s ANOVA-based test for multiple comparisons). Bars are Mean + SE
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Trl4, and Trl5 associated with BV/TV and Tb.Th, were
predominantly affected by the PWK founder strain. In
contrast, the loci associated with Tb.N and Conn.D
(Trl3 and Trl5, respectively) had a more varied founder
contribution.
Imputation identifies candidate genes
To pinpoint candidate genes we fine-tuned our model
using merge analysis (Fig. 6, [26]) to test the association
of variants imputed from the catalogue of variation in
the eight CC founders. When the logP value of the im-
putation test is lower than that of the haplotype analysis,
the SNPs at the QTL peak are unlikely to be causal; in
contrast when the merge logP is higher, it suggests that
the tested variant is consistent with being a quantitative
trait nucleotide (QTN), with the caveat that there may
be multiple variants with the same SDP that are equally
likely to be causal [34]. Filtering out SNPs with logP
values lower than that of the haplotype-scan peak SNPs
we were able to identify candidate genes.
The list of all potential causal variants identified by the
merge analysis is presented in Additional file 2: Table S3.
In accordance with the relatively wide 50 % CI of
Conn.D (Trl6), the peak of the haplotype analysis did
not contain the highest merge logP values; rather, these
lay within ±3 Mb from the inferred peak. Regarding Trl4
and Trl5 (Tb.Th), their 50 % CI is much narrower than
that of Trl6 (0.2 and 0.13 vs 9.94 Mb, respectively,
Table 2 and Additional file 4: Figure S3), but the peak of
the QTL lacks a high density of SNPs with merge logP
higher than the haplotype-scan logP threshold (Fig. 6).
Moreover, those present are multiallelic, a situation
which reflects the complexity observed in the predicted
founders’ haplotype effects, and suggesting the presence
of multiple causal variants (Fig. 6). To gain further
insight into the Trls, we included recombination rates
for the mouse at 4Ner/Kb, following Brunschwig et al.
[35] (Fig. 6); although most loci are in regions of mild
recombination rates, data for Trl3, 4, and 6 suggest that
these loci are in the vicinity of recombination hot spots.
We note that this did not alter the imputation perform-
ance (see Discussion).
We identified 11 potential genes for the six Trls; we
found three genes for BV/TV (Trl1 and Trl2), three for
Tb.N (Trl3), three for Tb.Th (Trl4 and Trl5), and two
for Conn.D (Trl6). Importantly, our analysis revealed
genes that already have well-documented functions in
bone biology as well as genes that have yet an unex-
plored role in the regulation of trabecular bone micro-
architecture (Additional file 2: Table S3).
Discussion
To our knowledge, this study is the first to use the CC
population in a genome-wide association analysis of
high-resolution trabecular bone traits. Our results repli-
cate previous association analyses, confirm previous in
vivo and in vitro experiments, and suggest new candi-
date genes for the regulation of trabecular bone micro-
structure. The roles of these latter genes will require
validation in future studies both in vivo and in vitro. We
thus provide a valuable resource for further research
aimed at understanding the underlying genetic determi-
nants of complex trabecular structure.
Our association analyses were enhanced by virtue of
ancestral sequence information that enabled us to de-
duce QTNs that segregate differentially in the CC lines,
thus reducing false positives and assisting in the identifi-
cation of potential candidate genes. This imputation’s
power depends on (a) the accuracy of the catalogues of
variants in the CC founders (as determined from rese-
quencing the strains by Keane et al. 2011 [7]) and (b)
the accuracy with which the genome mosaics of the CC
lines are determined from SNP genotypes using the
HAPPY R package. Whilst we cannot control for se-
quencing errors in the founders, any uncertainty in the
locations of mosaic breakpoints is encoded in the prob-
ability distribution of descent from each of the eight
founders. At loci with high certainty (which are the great
majority) the probability distribution is concentrated on
one founder which has a much higher probability (close to
1) than that other strains (all close to 0). Around break-
points the probability distribution transitions through a
short region of uncertainty in which the strain probabil-
ities are more equal. The way imputation (merge analysis)
is performed in the CC is to compute the dosage of a SNP
allele in a CC line by adding together the probabilities for
those founders carrying that allele in the variant catalogue.
Fig. 2 Two representative μCT images of the femoral trabecular
compartment. Left, IL-1513. Right, IL-2689. Note the structural
differences due solely to the genetic background
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This means that in regions of low certainty (where the
founders are equally likely) the dosage of the allele will be
approximately proportional to its frequency among the
founders. In regions of high certainty the dosage is domi-
nated by the founder strain with highest probability (i.e.,
the dosage will be close to 0 or 1). Genetic association
with the SNP is determined by linear regression on the
imputed dosages. The effect on association testing is that
at a given SNP, the majority of CC lines will have high-
confidence dosages close to 0 or 1, and a small minority
(those with breakpoints near the SNP) will have inter-
mediate dosages. These latter have relatively little impact
on the statistical significance of the association, which is
driven by the high-confidence lines.
We were able to narrow the interval to the kilo-base
range by coinciding the CI with the 99th percentile
threshold and imputation results for four out of six
QTLs, namely, Trl1, Trl2 (for BV/TV), Trl4, and Trl5
(for Tb.Th), and thus to focus on a more restricted num-











































Fig. 3 Sex effects on trabecular traits. Notched box-and-whisker plots demonstrating the interquartile range (IQR; median in bold, whiskers correspond
to ± 1.5 · IQR) for BV/TV (%), Tb.N (mm-1), Tb.Th (mm), and Conn.D (mm-3). Significance is reported in logP values (a negative log-transform of the P-value,
to emphasize the extent to which they differ). Note that except for Tb.Th, all traits had a significant sex effect (P< 0.01, or logP > 2)
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Our findings indicate 4 Trls for which there was a
strong founder effect by PWK. This emphasizes the ad-
vantage of the CC mouse panel, inasmuch as it includes 3
wild-derived strains, including the PWK strain. This strain
differs from classical laboratory strains by about 17 million
SNPs [7], and it is likely to carry rare variants not found in
the classical inbred strains. This unique allelic diversity
results in the presence of variants in more genes than in
inbred populations, thus enabling the detection of a larger
array of genes that contribute to the analyzed traits.
We detected 3 genes associated with BV/TV; two under
Trl1 and one under Trl2. Among these, Oxt encodes a pre-
cursor of oxytocin, and Avp encodes arginine-vasopressin.
Both of these proteins are hormones produced in the
hypothalamus and secreted from the posterior pituitary
gland, and differ from each other by only two amino acids.
Tamma et al. have previously shown that these hormones
have a direct skeletal effect – affecting BV/TV, Tb.N, and
Tb.Th - in both males and females. They act via the
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D
Fig. 4 QTL haplotype mapping of trabecular traits. Plots show –logP values according to the chromosome location (x-axis). Horizontal line
represent the 99th (solid) and 95th (dashed) percentile thresholds for genome-wide significance. a The scan for BV/TV yielded two proximal
QTLs, at chromosome 2, with their peaks at a -logP of 6.67 and 6.31, respectively. b Tb.N had a QTL at chromosome 8 with a -logP of 5.63. c Tb.Th had
two QTLs at chromosome 7 with a -logPs of 7.87 and 5.36. d Conn.D had a QTL at chromosome 14 with a -logP of 6.36
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Table 2 Positions of QTLs associated with trabecular traits
QTL Trait Chr logP 99th % threshold logP Sig H2r logP H
2
r 50 % CI 90 % CI 95 % CI
Simulation Li (2011)
Position Width (Mb) Position Width (Mb) Position Width (Mb) Position Width (Mb)
Trl1 BV/TV 2.00 6.67 5.01 0.01 0.60 2.46 130.48-130.68 0.20 129.9-130.5 0.60 128.08-132.8 4.70 126.2-135.6 9.40
Trl2 BV/TV 2.00 6.31 5.01 0.01 0.67 3.37 121.9-122.2 0.30 119.6-123.4 3.80 121.7-122.4 0.70 115.6-124.9 9.30
Trl3 Tb.N 8.00 5.63 4.88 0.01 0.61 2.42 37.2-40.47 3.27 37.8-41.2 3.40 31.8-43.9 12.40 30.8-46.9 16.10
Trl4 Tb.Th 7.00 7.87 5.14 0.01 0.86 6.75 64.6-64.8 0.20 63.7-65.6 1.90 63.8-65.7 1.90 62.7-68.1 5.40
Trl5 Tb.Th 7.00 5.36 5.14 0.01 0.73 12.77 73.4-73.5 0.13 73.2-73.7 0.52 70.4-75.1 4.74 66.01-77.9 10.73
Trl6 Conn.D 14.00 6.36 5.17 0.01 0.66 12.77 69.8-79.74 9.94 70.7-79.2 8.50 66.7-77.2 10.62 64.7-77.1 13.50
Chr chromosome; logP = negative 10-base logarithm of P value; Sig = genome-wide significance level; 99th % threshold logP = threshold used to define cut-off for QTL peaks (Fig. 4); Hr
2 = regional heritability. Positions













both osteoblasts and osteoclasts; it increases osteoblast dif-
ferentiation by upregulating bone morphogenic protein
(BMP) 2, and stimulates osteoclasts directly via activation
of NF-kB and MAP kinase signaling, and indirectly via in-
creasing RANK-L expression. Concordantly, Oxt-null mice
exhibit an osteoporosis phenotype [12]. Avp deficiency,
similarly, renders mice susceptible to bone loss via activa-
tion of the Avpr1a and Avpr2 G-protein coupled receptors,
present in both osteoclasts and osteoblasts, which in
turn activate the Erk pathway [13]. B2m encodes β2-
microglobulin, which is involved in the regulation of
the host immune response and is known to activate os-
teoclasts and osteoblasts in both sexes. It supports the
transition of epithelial to mesenchymal cells, thereby
promotes bone metastases originating from prostate,
breast, lung, and renal cancers [18]. It does so mainly
by interacting with hemochromatosis (HFE) protein.
HFE null mice were found to be phenotypically
identical to BMP2-null mice [36]. Further, men with a
mutation in HFE had significantly lower BMD [37].
Interestingly, a recent study found that lysyl oxidase




























































































































































































































































Fig. 5 Founder effects at each QTL. Each panel corresponds to one of the six mapped trabecular-related loci (Trl). The x-axis shows the eight founders
of the CC population and the y-axis shows the haplotype effects predicted from a regression fit to the founder haplotype probabilities at the QTL. All
effects are plotted relative to WSB which is arbitrarily set to 0. a Trl1 (BV/TV). b Trl2 (BV/TV). c Trl3 (Tb.N). d Trl4 (Tb.Th). e Trl5 (Tb.Th). f Trl6 (Conn.D)
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metastases [38]; BMP1 proteolytically cleaves Pro-LOX
to active LOX [39].
Under the QTL for Tb.N we identified Cnot7, Fgf20,
and Sgcz to be the most prominent contributors to the
phenotype. Cnot7 - or CCR4-NOT transcription com-
plex, subunit 7 - suppresses bone mass and inhibits
BMPs in osteoblasts [40]; Cnot7-null male mice had a sub-
stantial increase in bone mass, supposedly by inhibiting the
expression of alkaline phosphatase induced by BMPs in
osteoblastic cells. Fgf20 and Sgcz (fibroblast growth factor
and ζ-sarcoglycan, respectively) have no documented role
in bone metabolism. Fgf20 is a transcriptional target of
β-catenin which is important during Wnt signaling [41]
and interacts with BMP7 [42]. Wnt/β-catenin signaling is
an established pathway for normal bone homeostasis [43].
Sgcz is expressed in both striated and smooth muscles. Im-
portantly, bone and muscle share some common genes
[44]. As of yet, it remains unclear whether these proteins
affect both sexes equally and thus further work is needed to
examine their differential expression in males and females.
For Tb.Th the strongest candidate genes were Pcsk6,
Rgma, and Chd2. Pcsk6 encodes paired amino acid
Fig. 6 Merge analysis at each QTL. Each panel corresponds to one of the six mapped QTLs. The x-axis is the genome location; the left y-axis is
the logP of the association test between the trait and the locus; and the right y-axis is the recombination rate scale, in 4Ner/Kb. The continuous
black line is a section of the haplotype-based genome scans in Fig. 4. The red (MA; multiallelic) and gray (BA; biallelic) dots correspond to the
results of the merge analyses. Genes appear in the legend as colored bars from top to bottom as their order of appearance in the image, from
left to right. Dotted line is the 99th percentile threshold from Fig. 4. Blue continues line represents recombination rates. For clarity, merge logP
values below 4 are not shown. a Trl1 (BV/TV). b Trl2 (BV/TV). c Trl3 (Tb.N). d Trl4 (Tb.Th). e Trl5 (Tb.Th). f Trl6 (Conn.D)
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converting enzyme 4 (PACE4) which, in human females,
evokes proteolytic degradation of aggrecan, a major car-
tilage molecule, by activating the proteases ADAMTS-4
and pro-ADAMTS-4, thereby inducing the development
of osteoarthritis [45]. Interestingly, tibial trabecular bone
structure was found to be a good predictor of knee
osteoarthritis [46]. Rgma (encodes repulsive guidance
molecule A) has been shown to be a co-receptor of
BMP-2 and BMP-4, by binding directly to these factors,
and to mediate their signaling via BMP type I and II recep-
tors [36, 47, 48]. Based on the International Mouse Pheno-
typing Consortium database [49], both female and male
mice with mutant Chd2 (encodes chromodomain helicase
DNA binding protein 2) have a profoundly higher bone
mineral content and greater bone area, although these find-
ings have yet to be published in a peer-reviewed journal.
We speculate that putative skeletal role for genes asso-
ciated with Conn.D can be assigned to Cpb2, Rb1, and
Esd. Cpb2 (carboxypeptidase B2) has been implied to
confer a protective role in the pathogenesis of osteoarth-
ritis in male mice [50]. Rb1 was found to have a role in
osteogenesis [51]. Again, further work is needed to de-
termine if this role is sex-dependent.
Importantly, the peak of the QTL for Conn.D had al-
most no significant merge logP SNPs and the 50 % CI
was large enough to speculate that genes therein are
false positives; there reside Lrch1 (encodes Leucine-Rich
Repeats And Calponin Homology (CH) Domain Con-
taining 1) and Esd (encodes esterase D). Lrch1 was
found in a previous GWAS exploring the knee osteo-
arthritis phenotype in humans [52], but large-scale repli-
cation studies [53, 54] then dismissed it from being
casual. However, Esd was confirmed by microarray-
based qPCR analysis to influence spinal bone mineral
density in inbred rats [8] and thus seems to be a likely
candidate. Still, due to insufficient evidence in our and
previous studies, the role of these genes in bone micro-
structure remains unclear.
The genes aforementioned are most likely to explain
the Trls, based on published functionality assays. How-
ever, it is possible that other genes in the vicinity of
these loci are related to the traits examined. While these
cannot be ruled out conclusively without carrying out
particular validation experiments, they are unlikely to
play a prominent role in determining the trabecular
microstructure given their known molecular role. Of
note, considering the meaningful sex and age effect some
of the phenotypes exhibit, we expect some genes to have a
sex and age differential behavior, even though none of the
loci (and their human orthologues) were found on either
of the sex chromosomes (Additional file 2: Table S3).
Lastly, besides Avp and Oxt which are confirmed to affect
the microstructural parameters we studied here, others
have yet to be validated for these skeletal traits.
Conclusions
The variation of trabecular phenotypes between perfectly
viable CC lines reflects in many aspects the variance in
human populations. Whilst the complete complex spatial
and temporal interactions of the genes controlling tra-
becular traits cannot be expected to be identified with a
limited cohort size at our disposal, nevertheless, using a
relatively small cohort with sufficient replication in each
line, the wide phenotypic range of divergence enabled us
to dissect the genetic architecture of trabecular pheno-
types, and to direct previous genes associated with bone
to more refined trabecular microstructural parameters.
Methods
Mice
Mice aged 10 to 13 weeks (male n = 86; female n = 74),
from 31 different CC lines (average of 5 mice per line)
were used in this study. The mice were at inbreeding
generations of 11 to 37, which correspond to 80–99.9 %
genetic homozygosity, respectively. The mice were bred
and maintained at the small animal facility of the Sackler
Faculty of Medicine, Tel Aviv University (TAU), Israel.
They were housed on hardwood chip bedding in open-top
cages, with food and distilled water available ad libitum, in
an identical controlled environment (temperature = 25 ±
2 °C; 60 % ≤ humidity ≤ 85 %) and a 12 h light/dark cycle.
All experiments protocols were approved by the Insti-
tutional Animal Care and Use Committee (IACUC M-
13–014) at TAU, which follows the NIH/USA animal
care and use protocols.
Specimen collection
Mice were intraperitoneally euthanized with cervical dis-
location performed approximately one minute after
breathing stops owing to 5 % Isoflurane inhalation. Left
femora were harvested and fixed for 24 h in 4 % parafor-
maldehyde solution, and then stored in 70 % ethyl alcohol.
μCT evaluation
Whole left femora from each mouse were examined as de-
scribed previously [55] by a μCT system (μCT 50, Scanco
Medical AG, Switzerland). Briefly, scans were performed at
a 10-μm resolution in all three spatial dimensions. The min-
eralized tissues were differentially segmented by a global
thresholding procedure [56]. All morphometric parameters
were determined by a direct 3D approach [57]. Parameters
analyzed were determined in the metaphyseal trabecular
bone, which included trabecular bone volume fraction (BV/
TV), trabecular thickness (Tb.Th), trabecular number
(Tb.N), and trabecular connectivity density (Conn.D).
Genotyping
A representative male mouse from each line was initially
genotyped with a high mouse diversity array (MDA),
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which consists of 620,000 SNPs (Durrant et al., 2011).
After about two intervals of 4 generations of inbreeding,
all the CC lines were regenotyped by mouse universal
genotype array (MUGA, 7,500 markers) and finally with
the MegaMuga (77,800 markers) SNP array to confirm
their genotype status [21]. The founder-based mosaic of
each CC line was reconstructed using a hidden Markov
model in which the hidden states are the founder haplo-
types and the observed states are the CC lines, to pro-
duce a probability matrix of descent from each founder.
This matrix was then pruned to about 11,000 SNPs by
averaging across a window of 20 consecutive markers for
faster analyses and reduction of genotyping errors [58].
Statistical analyses
All statistical analyses were performed with the statistical
software R (R core development team 2009), including
the package happy.hbrem [59].
Heritability and sex and age effects
Broad-sense heritability (H2) was obtained for each trait
by fitting the trait (the independent variable) to the CC
line label in a linear regression model that incorporates
sex and age. ANOVA test was used to compare a null
model (in which all dependent variables are set to 0)
with linear models that fit the sex, age and the CC line
labels to the examined trait. Practically, the difference




of the covariates model and that of the CC-line labels
can be seen as the net genetic contribution to the trait.
Thus, this difference divided by that of the covariate
model gives an estimation of the heritability. Sex and
age effects were calculated separately, by dividing the
RSS difference between the null and full model with that
of the null model. Let F0 be the model that fits the trait
to the covariates; F1 the model that fits the trait to the
covariates and the CC line label; and F00 the null model.
Then, employing ANOVA, heritability is:
H2 ¼ RSS F0ð Þ−RSS F1ð Þð Þ = RSS F00ð Þ:
Similarly, sex and age effects are computed separately,
by fitting separately each covariate in F0. The covariate
effect is thus:
RSS F00ð Þ−RSS F1ð Þð Þ = RSS F00ð Þ:
Haplotype mapping
Each trait was fitted in a multiple linear regression
model to the probability matrix of descent from each
founder, including sex and age as covariates. The ex-












FLi s; tð Þβs
where μ is a normally distributed trait mean, with sex
and age incorporated; F
Li(s, t) is the probability of des-
cent from founders s and t; and βs + βt is the additive ef-





FLi s; tð Þ ¼ 2 for
a diploid organism, the maximum likelihood estimates
β^s are not independent. Thus, they are expressed here as
differences from the WSB/EiJ founder effect, so that
β^WSB ¼ 0 . Number of members per line was weighted
and integrated in the linear model. ANOVA was then
used to compare this model with a null model where the
founder effects are all set to 0; the resulting F-statistic
yielded the significance of the genetic model vs. the null
model and the negative 10-base logarithms of the P
values (logP) were recorded.
Permutations of the CC lines between the phenotypes
were used to set significance thresholds levels. Founder
effects are the estimates derived from the multiple linear
regression fit above.
Regional heritability (Hr
2) was hereafter computed by
ANOVA as in the broad-sense heritability computation,
except that here null linear regression fit was compared
with a genetic linear regression fit with the probability
matrix of the founder descent at the peak QTL as the
explanatory variable.
False discovery rate (FDR) was calculated using the
p.adjust function in R, with the method “BH”.
Confidence intervals
Confidence intervals (CIs) were obtained both by simu-
lations and by the quick method of Li, 2011 [33]. In the
simulations, we resampled the residuals of the original
linear regression fit at the peak of each QTL and
rescanned 100 intervals within 7–10 Mb of the original
loci to find the highest logP. Accordingly, following
Durrant et al. [27], 1000 QTLs were simulated: if t^ i is a
random permutation of the residuals of fitted genetic
model at the QTL peak, and K is a marker interval in a
neighborhood of 3.5 to 5 Mb of the QTL peak L, a set
of values for each trait, ZiK is provided by:







In the merge analysis the eight founder strains are parti-
tioned and merged according to the strain distribution
pattern (SDP) of the alleles at the quantitative trait
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nucleotides (QTN) within a given QTL (formerly ob-
tained by the initial mapping). If we denote the poly-
morphism as p, then Xp = 1 if s has allele a at p, and
Xp = 0 otherwise [34]. Then, at p, the probability of i to
inherit alleles a and b from s and t, respectively, within
L is
Gpi a; bð Þ ¼
X
s;t
Xp a; sð ÞXp b; tð ÞFLi s; tð Þ:
This merges the founder strains by p. The expected
trait value in the merged strains can now be inferred byX
a;b
Gpi a; bð Þ βa þ βb
 
:
Because this is a sub-model of the QTL model, it is ex-
pected to yield higher logP values due to a reduction in
the degrees of freedom. Significance was obtained by com-
paring the merge model with the QTL model. Individual
genes were extracted from the Sanger mouse SNP reposi-
tory (http://www.sanger.ac.uk/sanger/Mouse_SnpViewer).
Availability of supporting data
The data sets supporting the results of this article are
available in the GitHub repository: https://github.com/
roylv/avp.
Additional files
Additional file 1: Figure S1. Phenotypic diversity between the CC lines.
(A) phenotypic distribution among males and (B) females. From top-left,
counter-clockwise: trabecular bone volume fraction (BV/TV; %), trabecular
number (Tb.N; mm-1), thickness (Tb.Th; mm), and connectivity density
(Conn.D; mm-3). (DOC 400 kb)
Additional file 2: Table S1. Trait means. Table S2. Trait correlations.
Table S3. Candidate genes. (XLSX 17 kb)
Additional file 3: Figure S2. Haplotype mapping for the albino trait
using 38 CC lines. Plots show –logP values (y-axis) according to chromosome
location (x-axis). Horizontal line represent, top-to-bottom, the 95th, 90th, and
50th percentile thresholds, respectively. Peak is at 7.69 –logP. (PDF 54 kb)
Additional file 4: Figure S3. Confidence-interval simulations for QTL.
Loci at a neighborhood of 3-5 Mb around the original locus were simulated
by permuting the residual sum of squares of the related phenotype. Maximum
logP was obtained along with its relative position in Mb to the original QTL
(histograms, left panels), and with the number of markers from the original
QTL (boxplots, right panels). Simulations results for the BV/TV loci (Trl1 and
Trl2), determined with high confidence that the peak QTL is responsible for
the effect seen in the haplotype scan, thus the narrow CI; Trl3 histogram and
corresponding boxplot represent simulation results for Tb.N; plots for Trl4 and
Trl5 show simulations for Tb.Th; and Trl6 for Conn.D. Note the narrow CI for Trls
1, 2 (BV/TV), 4, and 5 (Tb.Th), wide for Trl3 (Tb.N), and wider still for Trl6
(Conn.D). (PDF 113 kb)
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